| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-05 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |